The High-level event on the EU-AU partnership in Global Health for Equitable Access shows the continued prominence of health in the EU-AU partnership. As many…
actionsantemondiale27 March 2024
HIV/AIDS, TB & Malaria, Promoting transparent and needs-driven EU R&D policies, Research and Development
In the run-up to World TB Day 2024, which takes place each year on March 24th, Global Health Advocates releases a brief paper advocating for…
actionsantemondiale22 March 2024
Two years after the last European Union (EU)-African Union (AU) Summit, Global Health Advocates (GHA) publishes a series of 3 policy briefs on the EU-AU…
actionsantemondiale18 March 2024
State Parties are still struggling to reach a consensus on the main equity-related provisions of the Pandemic Accord draft, resulting in stalled negotiations and growing…
actionsantemondiale16 February 2024
Global Health Advocates welcomes the Council's conclusions on the EU Global Health Strategy, yet regret the lack of concrete provisions on immunisation, access and equity,…
actionsantemondiale1 February 2024
ACCESS DENIED: What happens when Big Pharma is in the driver’s seat, Promoting transparent and needs-driven EU R&D policies
Last January, Global Health Advocates and partner STOPAIDS published a report series which explored how a lack of transparency in the pharmaceutical industry and the…
actionsantemondiale24 January 2024
8 CSOs call on the Belgian Presidency of the Council of the EU to adopt these 18 measures to deliver on Global Health.
actionsantemondiale22 January 2024
Our best wishes and proposed good resolutions for 2024!
actionsantemondiale1 January 2024
CSOs react to the latest deal on the table regarding the MFF revision which prioritises investments in migration management and slashes the new funding for…
actionsantemondiale15 December 2023
Global Health Advocates releases a new report on sustaining the health gains of polio eradication for a safer future, aiming to understand the remaining challenges…
actionsantemondiale13 December 2023
;
